BDC Laboratories Introduces Software to Simplify Complex GOA Determination for Prosthetic Heart Valves

Statys® GOA makes it possible to perform quantitative GOA analysis

Statys® GOA software

Biomedical Device Consultants and Laboratories (BDC Laboratories) introduced its Statys® GOA software today at MD&M West. This equipment-agnostic program simplifies and automates geometric orifice area (GOA) analysis in prosthetic heart valves.

GOA analysis is a multi-dimensional imaging challenge because heart valve substitutes have complex geometries and perform nuanced movements. Statys® GOA is the first purpose-built software for quantitative comparison of heart valve leaflet opening area between hydrodynamic testing and accelerated wear testing. It’s designed to help engineering teams better comply with ISO 5840.

Learn more about the software here: https://www.bdclabs.com/testing-equipment/statys-goa-software/

Analyzes Videos and Still Images

Statys® GOA automatically analyzes video and still images, overlays boundaries, and determines the GOA for each frame, making analysis efficient, accurate, and simple. Image contrast is crucial in GOA analysis because, without clear differentiation between the leaflet edges and the background, it’s challenging to achieve accurate measurements using edge detection. With multiple algorithms for tailoring analysis and correcting image quality, it’s easy to fix less-than-ideal lighting conditions that traditionally confound these measurements.

With an intuitive interface and automated report generation, it’s easy for anyone on the team to keep track of test results and avoid knowledge transfer gaps.

A Proven Path to GOA Analysis

“This software takes an esoteric, complex measurement and simplifies it,” said Craig Weinberg, PhD, Chief Technology Officer, BDC Laboratories. “It’s a very purpose-developed software. Statys® GOA does one thing really well—and that’s quantifying the opening area of a valve throughout the cardiac cycle.”

Today, some engineering teams create their own GOA analysis algorithms in general-purpose software platforms. With Statys® GOA, BDC Laboratories is leveraging decades of experience to ensure efficient and insightful GOA analysis, even for teams with limited resources.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.